SPACE-GM Microenvironment Analysis
Various Cancers
Key Facts
About Enable Medicine
Enable Medicine is a private, AI-driven digital health company founded in 2019, operating as a platform and services provider in the biotech sector. The company has developed a comprehensive cloud platform that indexes and analyzes vast amounts of multimodal biological data, such as spatial proteomics and single-cell data, to answer critical research questions in areas like patient stratification and target identification. It collaborates with over 200 entities in biopharma and academia, has indexed data from 60,000+ samples, and has been featured in 75+ published studies. Enable Medicine is in an early revenue stage, monetizing its AI-powered analysis platform and scientific services to accelerate therapeutic R&D for its partners.
View full company profileTherapeutic Areas
Other Various Cancers Drugs
| Drug | Company | Phase |
|---|---|---|
| Oncology/Immuno-oncology Portfolio | MSD | Phase III/Commercial |
| Bevacizumab Biosimilar | Dr. Reddy's Laboratories | Approved |
| LADR Platform | LadRx | Preclinical |
| NK Cell Stimulation (via JadiCell) | Therapeutic Solutions International | Preclinical |
| Zip-Code Library for Oncology | Kodikaz Therapeutic Solutions | Pre-clinical |
| Proprietary RLT Pipeline | Affibody | Not Specified (Preclinical-Phase 2) |
| Preclinical ASO Portfolio | Isarna Therapeutics | Preclinical |
| Oncology Program(s) | CIS Pharma | Pre-clinical |
| Max Access Solutions (with The Max Foundation) | Tanner Pharma Group | N/A (Donation/Distribution Program) |
| CPA Platform in Oncology | InnoSIGN | Development |
| Oncology Services | Transcure Bioservices | Preclinical |
| SBX 2021 | Stramsen Biotech | Early-stage Clinical |